Paras Healthcare Ltd
₹
- close price
About
[
edit about
]
[
add key points
]
- Market Cap ₹ 7,498 Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E 80.9
- Book Value ₹
- Dividend Yield %
- ROCE 13.0 %
- ROE 15.3 %
- Face Value ₹ 1.00
Pros
Cons
- Company has a low return on equity of 11.3% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Loading peers table ...
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| 776 | 879 | 1,010 | 1,137 | 1,368 | |
| 700 | 797 | 853 | 988 | 1,080 | |
| Operating Profit | 76 | 82 | 157 | 149 | 289 |
| OPM % | 10% | 9% | 16% | 13% | 21% |
| 21 | 26 | 35 | 39 | 48 | |
| Interest | 25 | 40 | 49 | 88 | 99 |
| Depreciation | 48 | 51 | 54 | 95 | 114 |
| Profit before tax | 23 | 16 | 89 | 4 | 124 |
| Tax % | 76% | 96% | 22% | 24% | 25% |
| 6 | 1 | 69 | 3 | 93 | |
| EPS in Rs | 0.57 | 0.06 | 7.08 | 0.33 | 9.18 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 16% |
| TTM: | 20% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 431% |
| TTM: | 2823% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 10% |
| 3 Years: | 11% |
| Last Year: | 15% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 4 | 4 | 10 | 10 | 10 |
| Reserves | 125 | 125 | 512 | 515 | 678 |
| 371 | 306 | 422 | 1,029 | 1,193 | |
| 420 | 757 | 463 | 235 | 229 | |
| Total Liabilities | 920 | 1,192 | 1,406 | 1,788 | 2,110 |
| 417 | 509 | 679 | 851 | 902 | |
| CWIP | 14 | 67 | 28 | 36 | 29 |
| Investments | 0 | 73 | 73 | 73 | 73 |
| 489 | 543 | 625 | 828 | 1,106 | |
| Total Assets | 920 | 1,192 | 1,406 | 1,788 | 2,110 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| 83 | 67 | 125 | 112 | 176 | |
| -117 | -128 | -205 | -203 | -271 | |
| -23 | 75 | 72 | 106 | 109 | |
| Net Cash Flow | -58 | 14 | -7 | 14 | 14 |
| Free Cash Flow | -22 | -2 | -29 | -4 | 38 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 137% | 81% | 86% | 82% | 78% |
Ratios
Standalone / View Consolidated
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor Days | 40 | 53 | 52 | 63 | 71 |
| Inventory Days | 21 | 25 | 29 | 25 | 25 |
| Days Payable | 202 | 173 | 151 | 193 | 167 |
| Cash Conversion Cycle | -141 | -95 | -71 | -105 | -70 |
| Working Capital Days | -38 | -182 | -66 | -90 | -71 |
| ROCE % | 12% | 20% | 7% | 13% |